Imported Fasciola hepatica infection in the United States and treatment with triclabendazole. - Wikidata - awgldk - TriplyDB

Imported Fasciola hepatica infection in the United States and treatment with triclabendazole.

Imported Fasciola hepatica infection in the United States and treatment with triclabendazole.

http://www.wikidata.org/entity/Q43628073

about

Nitazoxanide: a new broad spectrum antiparasitic agent Zoonotic helminth infections with particular emphasis on fasciolosis and other trematodiases.Sushi delights and parasites: the risk of fishborne and foodborne parasitic zoonoses in Asia.Triclabendazole for the treatment of fascioliasis and paragonimiasis.Domestically acquired fascioliasis in northern California.Diagnosis of human fascioliasis by stool and blood techniques: update for the present global scenario.Efficacy and tolerability of two single-day regimens of triclabendazole for fascioliasis in Peruvian children.Therapeutic endoscopic retrograde cholangiopancreatography for the treatment of Fasciola hepatica presenting as biliary obstruction.Fasciola hepatica: a cause of obstructive jaundice in an elderly man from Iran.Commercial watercress as an emerging source of fascioliasis in Northern France in 2002: results from an outbreak investigation.

P2860

Q28287647-D50F92FE-63FD-41A8-B480-BF2067DFD02C Q31080479-6BAD0639-B726-482C-BB35-A8DB6F22365C Q36277312-883441B2-5D55-42D5-8A7E-81F3A93287D0 Q36322074-A780777D-0C28-49D7-B311-4EF4B8B2CC03 Q37166192-50B9EDCA-A776-4BF2-8C1C-FD1A57F4F4D6 Q38235437-5C279F03-C501-45D1-BAFF-C14A9C3A5359 Q39201216-F3DF49A7-B904-4C5A-BFCD-59EBB1DEBA32 Q40466747-C4BCD370-CE25-47E7-BB8B-38941DD1411B Q43104858-7CADBA31-375C-4605-8E0B-6C35D2CC54F4 Q43333352-096B5F0D-4320-4884-8F3D-C1555307E3C5

P2860

Imported Fasciola hepatica infection in the United States and treatment with triclabendazole.

http://www.wikidata.org/entity/Q43628073

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年学术文章

@wuu

2001年学术文章

@zh-cn

2001年学术文章

@zh-hans

2001年学术文章

@zh-my

2001年学术文章

@zh-sg

2001年學術文章

@yue

2001年學術文章

@zh

2001年學術文章

@zh-hant

name

Imported Fasciola hepatica inf ...... reatment with triclabendazole.

@en

Imported Fasciola hepatica inf ...... reatment with triclabendazole.

@nl

type

label

Imported Fasciola hepatica inf ...... reatment with triclabendazole.

@en

Imported Fasciola hepatica inf ...... reatment with triclabendazole.

@nl

prefLabel

Imported Fasciola hepatica inf ...... reatment with triclabendazole.

@en

Imported Fasciola hepatica inf ...... reatment with triclabendazole.

@nl

P1433

Q43628073-81182022-4982-426C-A211-8744B2AB099A

P1476

Q43628073-344EA6A0-3D0E-475D-9F88-9902764EEB72

P2093

Q43628073-02D376B2-DB4D-4014-9C55-DD5389B04E68

Q43628073-5F624722-D1FF-470E-936B-C61E7CB85E9C

Q43628073-DE018557-F01D-4814-9A73-9D1E0AE54D4B

P2860

Q43628073-0695F301-EE15-4BF0-A540-46A94780C959

Q43628073-4E521027-1D76-42C1-9CEA-4493D58D4765

Q43628073-530C10DD-863A-427B-A673-28FEF1315453

Q43628073-545A5CDA-DD44-4252-B615-5CA9534428BB

Q43628073-59247695-4B5F-4918-9E06-2495B717C14B

Q43628073-7209E51E-0E72-43BD-BB87-89D386A5A5EE

Q43628073-8C270AE2-1011-4722-A31E-0627570F45AD

Q43628073-B8A401B9-2E3E-47BF-A92E-B8EA8CBFEBFB

Q43628073-CABA4407-C46F-40DF-B855-5539D6463FCF

P304

Q43628073-068640A1-AAD6-4F45-914A-F99C07EB104E

P31

Q43628073-261D62EF-65FA-4693-BED4-D36E6971389D

P356

Q43628073-7F905E10-E6C9-4F85-9135-CCB540BFD3FF

P407

Q43628073-98007D2B-4372-45C5-9A29-85391350AB5B

P433

Q43628073-591CC474-817F-4196-AF8E-556256D6552A

P478

Q43628073-5944C477-099A-425F-8450-85138CB8D867

P577

Q43628073-22F76BB1-9414-49E5-87EC-283B43696B09

P5875

Q43628073-B1D9DF9A-0AFD-492F-91E3-FC053A938AA8

P698

Q43628073-474EF4C0-041A-47F6-A9E0-30133E38DE57

P921

Q43628073-EE5417CB-89F7-4A95-80AE-857627E650B6

P356

P1433

Clinical Infectious Diseases

P1476

Imported Fasciola hepatica inf ...... reatment with triclabendazole.

@en

P2093

Brodie SB

http://www.w3.org/2001/XMLSchema#string

Graham CS

http://www.w3.org/2001/XMLSchema#string

Weller PF

http://www.w3.org/2001/XMLSchema#string

P2860

Fascioliasis: case reports and review.

Effect of food on the bioavailability of triclabendazole in patients with fascioliasis.

MR findings in human fascioliasis.

Fasciola hepatica human infection. Histopathological study of sixteen cases.

Fascioliasis in developed countries: a review of classic and aberrant forms of the disease.

The effect of the sulphoxide metabolite of triclabendazole ('Fasinex') on the tegument of mature and immature stages of the liver fluke, Fasciola hepatica.

Human fascioliasis successfully treated with triclabendazole.

Fasciola hepatica: disruption of the vitelline cells in vitro by the sulphoxide metabolite of triclabendazole.

Antibody profiles by EITB and ELISA of cattle and sheep infected with Fasciola hepatica.

P304

1-5

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/320870

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P577

2001-05-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11948867

http://www.w3.org/2001/XMLSchema#string

P698

11389487

http://www.w3.org/2001/XMLSchema#string

P921

travel-associated infection